Document is current
Any future updates will be listed below
-
Authors
Takeuchi, Masashi
Kawakubo, Hirofumi
Saito, Kosuke
Maeda, Yusuke
Matsuda, Satoru
Fukuda, Kazumasa
Nakamura, Rieko
Kitagawa, Yuko
- License Information
-
More Information
Article History
First Online: 5 August 2022
Disclosure
: Yuko Kitagawa received lecture fees from Chugai Pharmaceutical Co., Ltd.; Taiho Pharmaceutical Co., Ltd; Asahi Kasei Pharma Corporation; Otsuka Pharmaceutical Factory Inc.; Shionogi and Co., Ltd.; Nippon Covidien Inc., Ono Pharmaceutical Co., Ltd.; and Bristol-Myers Squibb K.K. Yuko Kitagawa was supported by grants from Chugai Pharmaceutical Co., Ltd.; Taiho Pharmaceutical Co., Ltd; Yakult Honsha Co. Ltd., Asahi Kasei Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.; Takeda Pharmaceutical Co., Ltd.; Ono Pharmaceutical Co., Ltd.; Tsumura and Co.; Kyouwa Hakkou Kirin Co., Ltd.; Dainippon Sumitomo Pharma Co., Ltd.; EA Pharma Co., Ltd.; Astellas Pharma Inc.; Toyama Chemical Co., Ltd.; Medicon Inc., Kaken Pharmaceutical Co. Ltd.; Eisai Co., Ltd.; Otsuka Pharmaceutical Factory Inc.; Teijin Pharma Limited; Nihon Pharmaceutical Co., Ltd.; and Nippon Covidien Inc. Yuko Kitagawa held an endowed chair provided by Chugai Pharmaceutical Co., Ltd.; and Taiho Pharmaceutical Co., Ltd. outside the submitted work.
